Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal prophylaxis in STEMI patients undergoing primary PCI
2009-017642-32Phase 4Completed
- Sponsor
- University Hospital Odense
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sodium bicarbonate and acetylcysteine in myocardial infarction (MI) and contrast-induced nephropathy (CIN), sponsored by University Hospital Odense. Primary endpoints: Change in serum creatinine from day 0 to day 3 after PCI and Change in serum creatinine from day 3 to day 30 after PCI. Started Jan 2010; status: completed.
02
Drugs
sodium bicarbonateacetylcysteine
03
Conditions
myocardial infarction (MI)contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on 2009-017642-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017642-32.